Authors:
van der Auwera, P
Platzer, E
Xu, ZX
Schulz, R
Feugeas, O
Capdeville, R
Edwards, DJ
Citation: P. Van Der Auwera et al., Pharmacodynamics and pharmacokinetics of single doses of subcutaneous pegylated human G-CSF mutant (Ro 25-8315) in healthy volunteers: Comparison with single and multiple daily doses of Filgrastim, AM J HEMAT, 66(4), 2001, pp. 245-251
Authors:
Druker, BJ
Talpaz, M
Resta, DJ
Peng, B
Buchdunger, E
Ford, JM
Lydon, NB
Kantarjian, H
Capdeville, R
Ohno-Jones, S
Sawyers, CL
Citation: Bj. Druker et al., Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinasein chronic myeloid leukemia., N ENG J MED, 344(14), 2001, pp. 1031-1037
Authors:
Druker, BJ
Sawyers, CL
Kantarjian, H
Resta, DJ
Reese, SF
Ford, JM
Capdeville, R
Talpaz, M
Citation: Bj. Druker et al., Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia withthe philadelphia chromosome., N ENG J MED, 344(14), 2001, pp. 1038-1042
Authors:
Joensuu, H
Roberts, PJ
Sarlomo-Rikala, M
Andersson, LC
Tervahartiala, P
Tuveson, D
Silberman, SL
Capdeville, R
Dimitrijevic, S
Druker, B
Demetri, GD
Citation: H. Joensuu et al., Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor., N ENG J MED, 344(14), 2001, pp. 1052-1056
Authors:
Eskens, FALM
Greim, GA
van Zuylen, C
Wolff, I
Denis, LJ
Planting, AST
Muskiet, FA
Wanders, J
Barbet, NC
Choi, L
Capdeville, R
Verweij, J
Hanauske, AR
Bruntsch, U
Citation: Falm. Eskens et al., Phase I and pharmacological study of weekly administration of the polyamine synthesis inhibitor SAM 486A (CGP 48 664) in patients with solid tumors, CLIN CANC R, 6(5), 2000, pp. 1736-1743
Authors:
Zhou, HH
Choi, L
Lau, H
Bruntsch, U
De Vries, EEGE
Eckhardt, G
Van Oosterom, AT
Verweij, J
Schran, H
Barbet, N
Linnartz, R
Capdeville, R
Citation: Hh. Zhou et al., Population pharmacokinetics/toxicodynamics (PK/TD) relationship of SAM486Ain phase I studies in patients with advanced cancers, J CLIN PHAR, 40(3), 2000, pp. 275-283
Authors:
Paridaens, R
Uges, DRA
Barbet, N
Choi, L
Seeghers, M
van der Graaf, WTA
Groen, HJM
Dumez, H
Van Buuren, I
Muskiet, F
Capdeville, R
van Oosterom, AT
de Vries, EGE
Citation: R. Paridaens et al., A phase I study of a new polyamine biosynthesis inhibitor, SAM486A, in cancer patients with solid tumours, BR J CANC, 83(5), 2000, pp. 594-601